tolbutamide has been researched along with sdz pco 400 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dunne, MJ; Finch, A; Harding, EA | 1 |
1 other study(ies) available for tolbutamide and sdz pco 400
| Article | Year |
|---|---|
Blockade of K+ channels in insulin-secreting cells by the 'potassium channel opener' SDZ PCO 400.
Topics: Animals; Benzopyrans; Cell Membrane; Cyclopentanes; Diazoxide; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Membrane Potentials; Phentolamine; Potassium Channel Blockers; Potassium Channels; Rats; Tolbutamide | 1993 |